Week In Review: How Trump's Policies Moved Stocks - October 26, 2019

China said to aim at buying at least $20B of agricultural products, Nike criticized by VP.

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap compiled by The Fly:

1. U.S., CHINA TRADE DISPUTE: China aims to buy at least $20B of agricultural products in a year if it signs a partial trade deal with the U.S., Bloomberg reported on Thursday, citing people familiar with the matter said. China would consider boosting purchases further in future rounds of trade talks, sources told Bloomberg. Publicly traded companies in the agriculture space include Agrium (AGU), Andersons (ANDE), Archer Daniels (ADM), Bayer's Monsanto (BAYRY), Bunge (BG), CF Industries (CF), Compass Minerals (CMP), Intrepid Potash (IPI), Potash (POT) and Syngenta (SYT).

On Friday, CNBC reported, citing a statement from the Office of the U.S. Trade Representative, that the U.S. and China have made progress in trade discussions and have come close to finalizing parts of their "phase one" deal. The agency issued a statement following a conversation U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin had with Chinese Vice Premier Liu He. "They made headway on specific issues and the two sides are close to finalizing some sections of the agreement. Discussions will go on continuously at the deputy level, and the principals will have another call in the near future," the USTR said, according to CNBC.

2. VP BLASTS NIKE, NBA: In a speech at the Woodrow Wilson International Center for Scholars about the future of the U.S. relationship with China, Vice President Mike Pence said, "Nike promotes itself as a so-called 'social-justice champion,' but when it comes to Hong Kong, it prefers checking its social conscience at the door." The vice president said Nike (NKE) removed Houston Rockets merchandise from shelves to join the Chinese government in protesting a tweet from the Rockets general manager on Hong Kong. "In siding with the Chinese Communist Party and silencing free speech, the NBA is acting like a wholly owned subsidiary of the authoritarian regime," Pence added.

3. FDA COMMISSIONER: President Trump intends to nominate Stephen Hahn, a radiation oncologist and chief medical executive at M.D. Anderson Cancer Center in Houston, as the next Food and Drug Administration commissioner next week, Thomas Burton of Wall Street Journal reports, citing people familiar with the situation. Hahn would replace acting FDA commissioner Ned Sharpless, whose acting term expires on November, 1, Burton said. Publicly traded companies in pharma space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).  

4. CHEVRON TO CONTINUE DRILLING IN VENEZUELA: The U.S. Treasury Department has renewed a license allowing Chevron (CVX) to continue drilling in Venezuela for an additional three months through January 22, Reuters' Timothy Gardner and Makini Brice reported earlier this week. The license renewal is viewed by some in the Trump administration as a win, including Secretary of State Mike Pompeo, who sees keeping a U.S. company in the South American country as an asset that could lead to a speedy recovery after any ouster of President Nicolas Maduro, the authors said. Other White House officials believe letting the company stay results in oil production that helps keep Maduro in power by letting him pay down debts, the publication added. 

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.